MET and acute myeloid leukemia: Nie et al. declared that dramatically decreased miR-204 was found in serum samples and cells of acute myeloid leukemia (AML), and its overexpression would repress cell proliferation, migration, invasion, and induce cell apoptosis by targeting Hepatocyte growth factor (HGF)/c-Met pathway [6].